Results | Latest & Breaking News on Results | Photos, Videos, Breaking Stories and Articles on Results

you are here: Home News

Jyothy Labs Q2 PAT seen up 26% YoY to Rs. 53.1 cr: Motilal Oswal
Jyothy Labs Q4 PAT may dip 25.8% YoY to Rs 37.4 cr: Motilal Oswal
Jyothy Labs Q2 PAT may dip 13.8% YoY to Rs 52.3 cr: Motilal Oswal
Jyothy Labs Q1 PAT may dip 4.2% YoY to Rs. 48 cr: Arihant Capital
Jyothy Labs Q4 PAT seen up 36.5% YoY to Rs 35.5 cr: Sharekhan
Jyothy Laboratories Q2 PAT may dip 0.1% YoY to Rs. 45.3 cr: Kotak
Jyothy Laboratories Q1 PAT seen up 25.1% YoY to Rs. 40.5 cr: ICICI Direct
Jyothy Laboratories sees soft Q4; valuation discount to peers merits attention
Jyothy Laboratories Q4 PAT may dip 7.4% YoY to Rs. 55.9 cr: ICICI Direct
Jyothy Laboratories (Standalone) Q4 PAT may dip 0.4% YoY to Rs. 60.1 cr: Kotak
Godrej Consumer Products: International business remains a drag; stay on the sidelines
Jyothy Laboratories (Standalone) Q3 PAT seen up 18.1% YoY to Rs. 44 cr: Kotak
Jyothy Laboratories Q2 PAT may dip 4.3% YoY to Rs. 40.5 cr: ICICI Direct
Jyothy Laboratories Q1 PAT seen up 141.6% YoY to Rs. 49.8 cr: ICICI Direct
Jyothy Laboratories Q4 PAT may dip 63.3% YoY to Rs. 40.3 cr: ICICI Direct
Expect margin to sustain between 15-16% for next few quarters: Jyothy Labs
Will clarify on Henkel deal by October 31: Jyothy Laboratories
See demand uptick after initial cash ban shocker: Jyothy Labs
Jyothy Lab Q1 PAT seen up 33.5% to Rs 59.5 cr: Axis Securities
Jyothy Labs Q3 profit seen up 38% led by Maxo, EBITDA growth
Ujala has no competiton; saw good growth in Q2: Jyothy Labs
Jyothy Labs Q2 profit seen up 19%, margin may rise
Jyothy Labs Q4 profit seen up 29% to Rs 27.6 cr: Poll
See H2 13-14% EBITDA margin; 20% FY15 profit growth: Jyothy
Hope to maintain 15% EBITDA margin going ahead: Jyothy Labs

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Jyothy Labs Q2 PAT seen up 26% YoY to Rs. 53.1 cr: Motilal Oswal

Jyothy Labs Q4 PAT may dip 25.8% YoY to Rs 37.4 cr: Motilal Oswal

Jyothy Labs Q2 PAT may dip 13.8% YoY to Rs 52.3 cr: Motilal Oswal

Jyothy Labs Q1 PAT may dip 4.2% YoY to Rs. 48 cr: Arihant Capital

Jyothy Labs Q4 PAT seen up 36.5% YoY to Rs 35.5 cr: Sharekhan

Jyothy Laboratories Q2 PAT may dip 0.1% YoY to Rs. 45.3 cr: Kotak

Jyothy Laboratories Q1 PAT seen up 25.1% YoY to Rs. 40.5 cr: ICICI Direct

Jyothy Laboratories sees soft Q4; valuation discount to peers merits attention

Jyothy Laboratories Q4 PAT may dip 7.4% YoY to Rs. 55.9 cr: ICICI Direct

Jyothy Laboratories (Standalone) Q4 PAT may dip 0.4% YoY to Rs. 60.1 cr: Kotak

Godrej Consumer Products: International business remains a drag; stay on the sidelines

Jyothy Laboratories (Standalone) Q3 PAT seen up 18.1% YoY to Rs. 44 cr: Kotak

Jyothy Laboratories Q2 PAT may dip 4.3% YoY to Rs. 40.5 cr: ICICI Direct

Jyothy Laboratories Q1 PAT seen up 141.6% YoY to Rs. 49.8 cr: ICICI Direct

Jyothy Laboratories Q4 PAT may dip 63.3% YoY to Rs. 40.3 cr: ICICI Direct

Expect margin to sustain between 15-16% for next few quarters: Jyothy Labs

Will clarify on Henkel deal by October 31: Jyothy Laboratories

See demand uptick after initial cash ban shocker: Jyothy Labs

Jyothy Lab Q1 PAT seen up 33.5% to Rs 59.5 cr: Axis Securities

Jyothy Labs Q3 profit seen up 38% led by Maxo, EBITDA growth

Ujala has no competiton; saw good growth in Q2: Jyothy Labs

Jyothy Labs Q2 profit seen up 19%, margin may rise

Jyothy Labs Q4 profit seen up 29% to Rs 27.6 cr: Poll

See H2 13-14% EBITDA margin; 20% FY15 profit growth: Jyothy

Hope to maintain 15% EBITDA margin going ahead: Jyothy Labs